Kevin Weisman

Kevin Weisman

Ask VT AI

View News Summary

Uruapan mayor Carlos Manzo fatally shot during Day of the Dead event, sparking outrage and calls for justice.
Trump orders resumption of nuclear tests, raising concerns about international agreements and lost expertise.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Latest News

Reacher Season 4 Recasts Jay Baruchel with Christopher Rodriguez-Marquette

100% left coverage1 source

Reacher Season 4 Recasts Jay Baruchel with Christopher Rodriguez-Marquette

100% left coverage1 source

Reacher Season 4 Recasts Jay Baruchel with Christopher Rodriguez-Marquette

Reacher Season 4 Recasts Jay Baruchel with Christopher Rodriguez-Marquette

Kevin Weisman, TV

Reacher Season 4 Adds Eight New Cast Members

100% left coverage2 sources

Kevin Weisman, TV

Reacher Season 4 Adds Eight New Cast Members

100% left coverage2 sources

Reacher Season 4 Adds Eight New Cast Members

Reacher Season 4 Adds Eight New Cast Members

Kevin Weisman, TV

Reacher Season 4 Adds New Cast, Updates Roles

50% left coverage2 sources

Kevin Weisman, TV

Reacher Season 4 Adds New Cast, Updates Roles

50% left coverage2 sources

Reacher Season 4 Adds New Cast, Updates Roles

Reacher Season 4 Adds New Cast, Updates Roles

Rick Hoffman Returns as Louis Litt in NBC's Suits LA Spinoff

100% left coverage1 source

Rick Hoffman Returns as Louis Litt in NBC's Suits LA Spinoff

100% left coverage1 source

Rick Hoffman Returns as Louis Litt in NBC's Suits LA Spinoff

Rick Hoffman Returns as Louis Litt in NBC's Suits LA Spinoff

Ask VT AI

View News Summary

Uruapan mayor Carlos Manzo fatally shot during Day of the Dead event, sparking outrage and calls for justice.
Trump orders resumption of nuclear tests, raising concerns about international agreements and lost expertise.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Kevin Weisman